The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer that changes blood cells. It usually develops in the bone marrow, the inner part of the bone that makes immature cells that eventually develop ...

Dana-Farber Cancer Institute researchers are leading three studies that yield new insights to help improve treatment for patients with acute myelogenous leukemia (AML). The research teams will present ...

Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...

Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 7-10. Improving access to life-saving therapies for blood disorders is the theme ...

A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include ...

Mocravimod is being investigated in a global MO-TRANS Phase 3 study in patients with acute myeloid leukemia undergoing allogeneic hematopoietic ...

The FDA has granted fast track designation to LBS-007 for the treatment of patients with acute myeloid leukemia.

Senti Biosciences reports promising Phase I results for SENTI-202 in acute myeloid leukemia, with two of three patients ...

Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential ...